Infections and Infectious Diseases - Drug Trials For Money

Evaluation of Doxycycline Post-exposure Prophylaxis to Reduce Sexually Transmitted Infections in PrEP Users and HIV-infected Men Who Have Sex With Men

Conditions: Gonorrhea; Chlamydia; Syphilis
Intervention: Drug: Doxycycline Hyclate Delayed-Release 200 mg
Sponsors: University of California, San Francisco; University of Washington; National Institute of Allergy and Infectious Diseases (NIAID); Mayne Pharma International Pty Ltd; San Francisco Department of Public Health
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
The drug https://cialico.com is absorbed very quickly. Usually, the medication reaches the highest concentration several hours after the use. Food consumption doesn’t influence the degree and rate of absorption of Cialis.

Condition: Feeding Disorders
Intervention: Device: Nasal Bridle
Sponsor: St. Louis University
Recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: MEDI8897; Drug: Placebo
Sponsor: MedImmune LLC
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

Conditions: HIV Infection; Opioid-use Disorder; Cardiovascular Diseases
Interventions: Drug: buprenorphine/naloxone; Drug: Methadone; Drug: Naltrexone Injection; Drug: Heroin
Sponsors: MetroHealth Medical Center; National Institute on Drug Abuse (NIDA)
Recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

Condition: Bacterial Infection
Interventions: Drug: Aztreonam; Drug: Ceftazidime-Avibactam
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

Condition: Recurrent Clostridium Difficile Infection
Interventions: Drug: Penn Microbiome Therapy – 001; Drug: Penn Microbiome Therapy – 002; Drug: Penn Microbiome Therapy – 003
Sponsor: University of Pennsylvania
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

Condition: Tuberculosis
Intervention:
Sponsor: Oxford Immunotec
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 4, 2019ClinicalTrials.govComments OffInfections and Infectious DiseasesAbility | Assessing | Test | TSPOT®.TB

Conditions: Chlamydia Trachomatis Infection; Neisseria Gonorrheae Infection
Interventions: Diagnostic Test: NeuMoDx CT/NG Assay; Diagnostic Test: FDA-cleared NAATs
Sponsors: NeuMoDx Molecular, Inc.; NAMSA
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 3, 2019ClinicalTrials.govComments OffInfections and Infectious DiseasesEvaluation | NeuMoDx | Plan | Predicting | Study

Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: BIIB017 (peginterferon beta-1a); Drug: Interferon beta type 1a
Sponsor: Biogen
Recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

Condition: Healthy
Interventions: Biological: Ad26.Mos4.HIV; Biological: Clade C and Mosaic gp140 HIV bivalent vaccine; Biological: Placebo
Sponsor: Janssen Vaccines & Prevention B.V.
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days